Pheno Therapeutics
PrivateLast Round
Series A
Feb 18, 2020
Total Funding Raised
$6.5M
Company Overview
Pheno Therapeutics operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Series A round in February 2020.
Pheno Therapeutics is a biotechnology company that develops remyelinating therapies designed to halt disability progression in demyelinating diseases such as multiple sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheno Therapeutics Comparables
Compare Pheno Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rewind Therapeutics | 86% | |
| Convelo Therapeutics | 86% | |
| Myrobalan Therapeutics | 85% |
For institutional investors. Book with your work email.
Pheno Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pheno Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advent Life Sciences | Series A |
| LifeArc | Series A |
| Scottish Investment Bank (Scottish Enterprise) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 68% MoM, reaching 2.2K.
- Mar 1, 2026
Monthly visitors grew 32% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Pheno Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pheno Therapeutics's valuation, stock price, and market status.
Is Pheno Therapeutics a public or private company?
Pheno Therapeutics is a private company.
What is the current stock price of Pheno Therapeutics?
Pheno Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pheno Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pheno Therapeutics worth (valuation)?
Valuation information for Pheno Therapeutics is not publicly available.
Can I buy Pheno Therapeutics stock?
Pheno Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pheno Therapeutics's last funding round?
Pheno Therapeutics's most recent funding round was Series A on February 18, 2020.
Who are the main investors in Pheno Therapeutics?
Key investors in Pheno Therapeutics include Advent Life Sciences, LifeArc, Scottish Investment Bank (Scottish Enterprise).
Will Pheno Therapeutics IPO soon?
No public IPO plans have been announced for Pheno Therapeutics.
How can I track Pheno Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pheno Therapeutics's shares on secondary markets.